Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Mecwins Developing 'Highly Sensitive' Plasmonic Testing Tech for Laboratories, Point of Care
Premium
The firm recently inked an agreement with Quidel to enable the codevelopment of its technology for testing in doctors' offices and other decentralized settings.
Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO
Lucid Diagnostics said it markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for the early detection of esophageal precancer and cancer.
IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio'
The partnership with lab partner P4 Diagnostix aims to fast-track liquid biopsy diagnostic tests across pulmonary, metabolic, and women's health diseases.
Paige Obtains FDA De Novo Authorization for AI-Based Pathology Software to Diagnose Prostate Cancer
The firm said that in a clinical study pathologists using its Paige Prostate product had a 70 percent reduction in false negative diagnoses.
Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response.